ATE353956T1 - Methoden zur virus-reinigung - Google Patents

Methoden zur virus-reinigung

Info

Publication number
ATE353956T1
ATE353956T1 AT97950805T AT97950805T ATE353956T1 AT E353956 T1 ATE353956 T1 AT E353956T1 AT 97950805 T AT97950805 T AT 97950805T AT 97950805 T AT97950805 T AT 97950805T AT E353956 T1 ATE353956 T1 AT E353956T1
Authority
AT
Austria
Prior art keywords
cleaning methods
virus cleaning
virus
methods
purifying
Prior art date
Application number
AT97950805T
Other languages
English (en)
Inventor
John Chu-Tay Tang
Gary J Vellekamp
Laureano L Bondoc Jr
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE353956T1 publication Critical patent/ATE353956T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97950805T 1996-12-13 1997-12-11 Methoden zur virus-reinigung ATE353956T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76683596A 1996-12-13 1996-12-13

Publications (1)

Publication Number Publication Date
ATE353956T1 true ATE353956T1 (de) 2007-03-15

Family

ID=25077670

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97950805T ATE353956T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung
AT06006494T ATE477320T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06006494T ATE477320T1 (de) 1996-12-13 1997-12-11 Methoden zur virus-reinigung

Country Status (9)

Country Link
EP (2) EP0948601B1 (de)
JP (3) JP2001506126A (de)
AT (2) ATE353956T1 (de)
AU (1) AU5370598A (de)
CA (1) CA2274876A1 (de)
DE (2) DE69739961D1 (de)
ES (2) ES2283032T3 (de)
IL (1) IL130198A (de)
WO (1) WO1998026048A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022588A2 (en) 1996-11-20 1998-05-28 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
FR2787465A1 (fr) 1998-12-21 2000-06-23 Transgene Sa Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
WO2000050573A1 (fr) 1999-02-22 2000-08-31 Transgene S.A. Procede d'obtention d'une preparation virale purifiee
SE9904272D0 (sv) * 1999-11-25 1999-11-25 Amersham Pharm Biotech Ab A method for selective removal of a substance from samples containing compounds having nucleic acid structure
JP2005523722A (ja) 2002-04-30 2005-08-11 オンコリティクス バイオテック， インコーポレイティッド 改善されたウイルス精製方法
DE602004031681D1 (de) 2003-07-21 2011-04-14 Transgene Sa Multifunktionelle Cytokine
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
CA2586107A1 (en) 2004-11-03 2006-05-18 Introgen Therapeutics Inc. A novel method for the production and purification of adenoviral vectors
EP2066418A4 (de) 2006-09-29 2011-12-28 Ge Healthcare Bio Sciences Ab Trennmatrix für die virusreinigung
PE20081723A1 (es) 2007-01-30 2008-12-14 Transgene Sa Vacuna contra el papilomavirus
JP2010193720A (ja) * 2009-02-23 2010-09-09 Asahi Kasei Chemicals Corp アニオン交換基が固定された多孔膜を用いたウイルスの分離方法
BR112012002628B1 (pt) 2009-08-07 2021-09-08 Transgene Sa Composição imunogênica, molécula de ácido nucleico, vetor, partícula viral infecciosa, micro-organismo transgênico, composição, usos da composição imunogênica e kit de partes
GB201011502D0 (en) * 2010-07-08 2010-08-25 Glaxosmithkline Biolog Sa Novel process
CN105821078A (zh) 2010-12-09 2016-08-03 巴斯德研究所 用于获得高产量重组蛋白表达的基于mgmt的方法
TWI623618B (zh) 2011-07-12 2018-05-11 傳斯堅公司 Ｈｂｖ聚合酶突變體
WO2013045658A1 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
WO2013045668A2 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
IN2015DN02055A (de) 2012-09-17 2015-08-14 Grace W R & Co
EP3587455A1 (de) 2012-10-23 2020-01-01 Emory University Gm-csf- und il-4-konjugate, zusammensetzungen und zugehörige verfahren
ES3011733T3 (en) 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
EP3452081A1 (de) 2016-05-04 2019-03-13 Transgene SA Kombinationstherapie mit cpg-tlr9-liganden
EP3522920A2 (de) 2016-10-10 2019-08-14 Transgene SA Immuntherapeutisches produkt und mdsc-modulator-kombinationstherapie
US11826423B2 (en) 2016-11-16 2023-11-28 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
US11203629B2 (en) 2017-04-22 2021-12-21 Immunomic Therapeutics, Inc. LAMP constructs
CA3061950A1 (en) 2017-05-02 2018-11-08 Immunomic Therapeutics, Inc. Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
US11603527B2 (en) * 2017-12-27 2023-03-14 Global Life Sciences Solutions Usa Llc Method and kit for viral vector isolation
EP3793595A1 (de) 2018-05-15 2021-03-24 Immunomic Therapeutics, Inc. Verbesserte lamp-konstrukte mit allergenen
EP3833398A4 (de) 2018-09-21 2021-12-22 University of Connecticut Zusammensetzungen und verfahren zur wiederherstellung der paternalen ube3a-genexpression bei angelman-syndrom beim menschen
GB201820806D0 (en) 2018-12-20 2019-02-06 Ge Healthcare Bioprocess R&D Ab Large pore agarose
TWI852977B (zh) 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
WO2021011436A1 (en) * 2019-07-12 2021-01-21 Sangamo Therapeutics, Inc. Separation and quantification of empty and full viral capsid particles
JP2022551732A (ja) 2019-10-18 2022-12-13 イミュノミック セラピューティックス， インコーポレイテッド がん抗原を含む改良ｌａｍｐ構築物
CN114980920A (zh) 2019-11-18 2022-08-30 詹森生物科技公司 基于突变体calr和jak2的疫苗及其用途
TW202144388A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在卵巢癌中表現之新抗原及其用途
TW202144389A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在多發性骨髓瘤中表現之新抗原及其用途
EP4135757A1 (de) 2020-04-13 2023-02-22 Janssen Biotech, Inc. Psma- und steap1-impfstoffe und ihre verwendungen
WO2022009051A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
US20230024133A1 (en) 2020-07-06 2023-01-26 Janssen Biotech, Inc. Prostate Neoantigens And Their Uses
US12497598B2 (en) 2020-07-17 2025-12-16 Hvidovre Hospital Method of purifying whole virus particles
CA3247515A1 (en) 2022-04-10 2023-10-19 Immunomic Therapeutics, Inc. Bicistronic lamp constructions comprising genes that enhance the immune response and methods of their use
WO2025158316A1 (en) 2024-01-26 2025-07-31 Janssen Biotech, Inc. Ovarian neoantigens and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
FR2696748B1 (fr) 1992-10-14 1994-12-30 Pasteur Merieux Serums Vacc Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV).
DE69434594T2 (de) * 1993-10-25 2006-09-21 Canji, Inc., San Diego Rekombinante adenoviren-vektor und verfahren zur verwendung
AU722196B2 (en) 1995-08-30 2000-07-27 Genzyme Corporation Chromatographic purification of adenovirus and AAV
CZ438398A3 (cs) 1996-07-01 1999-03-17 Rhone-Poulenc Rorer S. A. Způsob přípravy rekombinantních adenovirů

Also Published As

Publication number Publication date
EP0948601B1 (de) 2007-02-14
JP2001506126A (ja) 2001-05-15
WO1998026048A1 (en) 1998-06-18
JP2005318898A (ja) 2005-11-17
AU5370598A (en) 1998-07-03
EP1679368A1 (de) 2006-07-12
IL130198A (en) 2005-09-25
EP0948601A1 (de) 1999-10-13
IL130198A0 (en) 2000-06-01
DE69739961D1 (de) 2010-09-23
EP1679368B1 (de) 2010-08-11
CA2274876A1 (en) 1998-06-18
DE69737364T2 (de) 2007-11-29
JP2009022292A (ja) 2009-02-05
DE69737364D1 (de) 2007-03-29
ES2349046T3 (es) 2010-12-22
ES2283032T3 (es) 2007-10-16
ATE477320T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
ATE477320T1 (de) Methoden zur virus-reinigung
DE69323983D1 (de) Methode zur Modifizierung des Fettdruckes von Buchstaben
EP0683595A3 (de) Vorrichtung zur Erzeugung eines Bildes.
BR0103212B1 (pt) purificador de ar.
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE69104274D1 (de) Verfahren zur Beseitigung von Kohlendioxid.
DE69723153D1 (de) Elektronen-emittierende Vorrichtung.
DE69530599D1 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
DE19881185D2 (de) Vorrichtung zur Zerstörung bzw. Zertrümmerung von Konkrementen
JPH11510143A5 (de)
DE69501300D1 (de) Verfahren zur reinigung von fluormethyl-1,1,1,3,3,3-hexafluorisopropylether
EP0588057A3 (de) Verfahren zur Optimierung des Arbeitsvorgangs eines Elektrohandwerkzeugs.
BR0101237B1 (pt) depurador de ar.
DE69426837D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluoro-2,3-dichloropropan
DE69112391D1 (de) Verfahren zur reinigung von fluorwasserstoff.
TR199501263A2 (tr) Agiz yoluyla alinan sabeluzol süspansiyonlari.
DE122006000019I2 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
ITTO940513A0 (it) Fanale per veicoli.
ES1029450Y (es) Ambientador para vehiculos.
IT236070Y1 (it) Luce per veicoli industriali.
ID16843A (id) Alat pembersih.
FI956215A7 (fi) Menetelmä 5H-dibentso-(b,f)-atsepiinin puhdistamiseksi
DE69823886D1 (de) Vorrichtung zur filtrierung von wasser
DE59909959D1 (de) Verfahren zur aufreinigung von (+-)2-azabicyclo (2.2.1)hept-5-en-3-on
DE69721065D1 (de) Verfahren zur reiningung von 1,3,5-triisopropylbenzol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties